Interventional nanotheranostics in hepatocellular carcinoma

Chavda, Vivek P.; Balar, Pankti C.; Patel, Srushti B.

doi:10.7150/ntno.80120



Theranostics

International Journal of Biological Sciences

International Journal of Medical Sciences

Journal of Cancer

Global reach, higher impact

Full Text | PDF

Nanotheranostics 2023; 7(2):128-141. doi:10.7150/ntno.80120 This issue Cite

Review

Interventional nanotheranostics in hepatocellular carcinoma

Vivek P. Chavda^1✉, Pankti C. Balar², Srushti B. Patel³

1. Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad, India.
2. Pharmacy Section, L.M. College of Pharmacy, Ahmedabad, India.
3. Pharmacy Section, Government Pharmacy College, Gandhinagar, India.

Citation:

Chavda VP, Balar PC, Patel SB. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics 2023; 7(2):128-141. doi:10.7150/ntno.80120. https://www.ntno.org/v07p0128.htm

Other styles

Abstract

Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances of damage to surrounding tissue. It ensures the highest efficiency for the management of the disease. Imaging is the near future for the quickest and most accurate detection of disease. After combing both effective measures, it ensures the most meticulous drug delivery system. Nanoparticles such as Gold NPs, Carbon NPs, Silicon NPS, etc. The article emphasizes on effect of this delivery system in the treatment of Hepatocellular Carcinoma. It is one of the widely spreading diseases and theranostics is trying to make the scenario better. The review suggests the pitfall of the current system and how theranostics can help. It describes the mechanism used to generate its effect and believes that interventional nanotheranostics do have a future with rainbow color. The article also describes the current hindrance to the flourishing of this miraculous technology.

Keywords: Interventional Nanotheranostics, HCC, Nanoparticle, Liver Cancer, SELEX

Citation styles

APA

Chavda, V.P., Balar, P.C., Patel, S.B. (2023). Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics, 7(2), 128-141. https://doi.org/10.7150/ntno.80120.

ACS

Chavda, V.P.; Balar, P.C.; Patel, S.B. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics 2023, 7 (2), 128-141. DOI: 10.7150/ntno.80120.

NLM

Chavda VP, Balar PC, Patel SB. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics 2023; 7(2):128-141. doi:10.7150/ntno.80120. https://www.ntno.org/v07p0128.htm

CSE

Chavda VP, Balar PC, Patel SB. 2023. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics. 7(2):128-141.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.